Free tool
FAERS Monitor: Technescan Mag3
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019882 or its brand name (Technescan Mag3, Technetium Tc-99m Mertiatide Kit). Reports on generic versions are filed under their own applications.
Reports
103
Serious
42
41% of reports
Hospitalization
12
Death reported
5
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective16
- dyspnoea11
- radioisotope scan abnormal9
- renal scan abnormal8
- syncope8
- tachycardia7
- drug dispensing error6
- nausea6
- rash6
- vomiting6
- urticaria5
- wrong drug administered5
- dizziness4
- headache4
- hyperhidrosis4
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 10 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 7 |
| 2018 | 10 |
| 2019 | 19 |
| 2020 | 22 |
| 2021 | 8 |
| 2022 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,056 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| renal scan abnormalSignal | 8 | 25956.6 | 12763.4 | 161,930 |
| radioisotope scan abnormalSignal | 9 | 2635.6 | 1405.8 | 20,873 |
| wrong drug administeredSignal | 5 | 114.6 | 48.7 | 455 |
| drug dispensing errorSignal | 6 | 80.2 | 36.9 | 394 |
| syncopeSignal | 8 | 16.3 | 8.4 | 101 |
| tachycardiaSignal | 7 | 16.1 | 7.9 | 85 |
| hyperhidrosisSignal | 4 | 6.3 | 2.4 | 13 |
| urticariaSignal | 5 | 6.1 | 2.6 | 17 |
| dyspnoeaSignal | 11 | 4.0 | 2.3 | 22 |
| rashSignal | 6 | 2.8 | 1.3 | 5 |
| vomitingSignal | 6 | 2.6 | 1.2 | 5 |
| drug ineffectiveSignal | 16 | 2.5 | 1.6 | 14 |
| dizziness | 4 | 1.6 | 0.6 | 0 |
| nausea | 6 | 1.5 | 0.7 | 1 |
| headache | 4 | 1.3 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.